Show simple item record

dc.contributor.authorThomsen, Liv Cecilie Vestrheimen_US
dc.contributor.authorMcCarthy, Ninaen_US
dc.contributor.authorMelton, Philip E.en_US
dc.contributor.authorCadby, Gemmaen_US
dc.contributor.authorAustgulen, Rigmoren_US
dc.contributor.authorNygård, Ottaren_US
dc.contributor.authorJohnson, Matthew Pen_US
dc.contributor.authorBrennecke, Shaun P.en_US
dc.contributor.authorMoses, Eric Ken_US
dc.contributor.authorBjørge, Lineen_US
dc.contributor.authorIversen, Ann-Charlotteen_US
dc.PublishedThomsen LC, McCarthy N, Melton PE, Cadby G, Austgulen R, Nygård O, Johnson MP, Brennecke SP, Moses EK, Bjørge L, Iversen A. The antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsia . Journal of Hypertension. 2017;35:132-139eng
dc.description.abstractObjective: Preeclampsia is a complex heterogeneous disease commonly defined by new-onset hypertension and proteinuria in pregnancy. Women experiencing preeclampsia have increased risk for cardiovascular diseases (CVD) later in life. Preeclampsia and CVD share risk factors and pathophysiologic mechanisms, including dysregulated inflammation and raised blood pressure. Despite commonalities, little is known about the contribution of shared genes (pleiotropy) to these diseases. This study aimed to investigate whether genetic risk factors for hypertension or inflammation are pleiotropic by also being associated with preeclampsia. Methods: We genotyped 122 single nucleotide polymorphisms (SNPs) in women with preeclampsia (n = 1006) and nonpreeclamptic controls (n = 816) from the Norwegian HUNT Study. SNPs were chosen on the basis of previously reported associations with either nongestational hypertension or inflammation in genome-wide association studies. The SNPs were tested for association with preeclampsia in a multiple logistic regression model. Results: The minor (G) allele of the intronic SNP rs17367504 in the gene methylenetetrahydrofolate reductase (MTHFR) was associated with a protective effect on preeclampsia (odds ratio 0.65, 95% confidence interval 0.53–0.80) in the Norwegian cohort. This association did not replicate in an Australian preeclampsia case–control cohort (P = 0.68, odds ratio 1.05, 95% confidence interval 0.83–1.32, minor allele frequency = 0.15). Conclusion: MTHFR is important for regulating transmethylation processes and is involved in regulation of folate metabolism. The G allele of rs17367504 has previously been shown to protect against nongestational hypertension. Our study suggests a novel association between this allele and reduced risk for preeclampsia. This is the first study associating the minor (G) allele of a SNP within the MTHFR gene with a protective effect on preeclampsia, and in doing so identifying a possible pleiotropic protective effect on preeclampsia and hypertension.en_US
dc.publisherWolters Kluwereng
dc.rightsAttribution CC BY-NC-NDeng
dc.subjectblood pressure regulationeng
dc.subjectmethylenetetrahydrofolate reductaseeng
dc.subjectsingle nucleotide polymorphismeng
dc.titleThe antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsiaen_US
dc.typePeer reviewed
dc.typeJournal article
dc.rights.holderCopyright 2016 Wolters Kluwer Health, Inc.
dc.source.journalJournal of Hypertension
dc.relation.projectNorges forskningsråd: 205400
dc.relation.projectNorges forskningsråd: 223255

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution CC BY-NC-ND
Except where otherwise noted, this item's license is described as Attribution CC BY-NC-ND